{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Lenexa",
      "state": "KS",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "73658",
      "recalling_firm": "Remel Inc",
      "address_1": "12076 Santa Fe Trail Dr",
      "address_2": "N/A",
      "postal_code": "66215-3519",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "US distribution in MO.",
      "recall_number": "Z-1921-2016",
      "product_description": "Oxoid Nitrocefin (+ Reconstitution Fluid Batch) REF: SR0112C, Oxoid Ltd.  For the rapid chromogenic detection of beta-lactamase activity in bacterial cells. in vitro diagnostic",
      "product_quantity": "2 units were imported and distributed domestically",
      "reason_for_recall": "Individual bottles of product may produce weak beta-lactamase reactions.  Use may result in delayed or false negative reporting.",
      "recall_initiation_date": "20160324",
      "center_classification_date": "20160607",
      "termination_date": "20170213",
      "report_date": "20160615",
      "code_info": "Lot 1717357 Exp: 31Aug2017"
    }
  ]
}